Efficacy and Safety of Ivabradine in Patients with Chronic Systolic Heart Failure According to Blood Pressure Level in SHIFT
Authors:
- Michel KomajdaMKMichel Komajda
- on behalf of the SHIFT InvestigatorsOIon behalf of the SHIFT Investigators
Open Access
- 24 June 2014
- journal article
- research article
- Published by Oxford University Press (OUP) in European Journal of Heart Failure
- Vol. 16 (7) , 810-816
Abstract
Aims Low systolic blood pressure (SBP) is associated with poor outcomes in heart failure and complicates management. In a post hoc analysis, we investigated the efficacy and safety of ivabradine in the SHIFT population divided by tertiles of baseline SBP. Methods and Results The analysis comprised 2110 patients with SBP P interaction = 0.68]. Similar results were found for cardiovascular mortality (P interaction = 0.91), hospitalization because of heart failure (P interaction = 0.79), all‐cause mortality (P interaction = 0.90), and heart failure mortality (P interaction = 0.18). There was no evidence for a difference in safety profile according to SBP group. Conclusion The efficacy and safety of ivabradine is independent of SBP. This may have implications for the management of HF patients with low SBP and elevated heart rate.Keywords
This publication has 24 references indexed in Scilit:
- Clinical profile and prognostic value of low systolic blood pressure in patients hospitalized for heart failure with reduced ejection fraction: Insights from the Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST) trialAmerican Heart Journal, 2013
- Current management and future directions for the treatment of patients hospitalized for heart failure with low blood pressureHeart Failure Reviews, 2012
- Titration to Target Dose of Bisoprolol vs. Carvedilol in Elderly Patients with Heart Failure: The CIBIS-ELD TrialEuropean Journal of Heart Failure, 2011
- Relation of Baseline Systolic Blood Pressure and Long-Term Outcomes in Ambulatory Patients With Chronic Mild to Moderate Heart FailureThe American Journal of Cardiology, 2011
- Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled studyThe Lancet, 2010
- Clinical Outcomes According to Baseline Blood Pressure in Patients With a Low Ejection Fraction in the CHARM (Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity) ProgramJACC, 2008
- Relation of Systolic Blood Pressure to Survival in Both Ischemic and Nonischemic Systolic Heart FailureThe American Journal of Cardiology, 2008
- Multiple Neurohumoral Modulating Agents in Systolic Dysfunction Heart Failure: Are We Lowering Blood Pressure Too Much?Journal of Cardiac Failure, 2008
- Quantifying the paradoxical effect of higher systolic blood pressure on mortality in chronic heart failureHeart, 2008
- Systolic Blood Pressure at Admission, Clinical Characteristics, and Outcomes in Patients Hospitalized With Acute Heart FailureJAMA, 2006